Work

Living with age-related macular degeneration treatment: Patient experiences of being treated with ranibizumab (Lucentis) (R) intravitreal injections

Year: 2013

Type: article

Abstract: This study reports the results of a qualitative study of patient experiences of receiving treatment for wet age-related macular degeneration with ranibizumab (Lucentis) (R) . Treatment involved monthly hospital visits for assessment and, where required, an intravitreal Lucentis injection. Qualitative narrative interviews were conducted with 22 patients, 18 of whom received treatment and were interviewed at two points during their treatment journey. Interviews allowed participants to reflect on their experiences of being assessed for and receiving this treatment. Overall, treated participants reported that while they had been apprehensive about treatment, the actual experience of it was far less unpleasant than they had expected. However, the data also revealed a number of issues surrounding the provision of information about treatment, as well as service delivery issues, which had considerable impact upon their experience.

Source: British Journal of Visual Impairment

DOI: 10.1177/0264619613481778

Authors: Clare Thetford, Suzanne Hodge, Simon Harding, Sandra Taylor, Paul C Knox

Institutions: University of Liverpool, Lancaster University, Royal Liverpool University Hospital

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650